No profile data available.
Capricor Therapeutics, Inc. (CAPR) is a healthcare company in the brain and nerve treatment drugs industry, based in San Diego, United States, with about 160 full-time employees.
In Q2 2026 (the quarter ended June 30, 2026) revenue was $0. Its market capitalization was $1.16 billion as of December 4, 2025.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of December 4, 2025.
, a clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States.
$1.16 billion as of December 4, 2025.
Listed companies of a similar size in the same industry (brain and nerve treatment drugs) include Mind Medicine (MindMed) Inc. (MNMD), GH Research PLC (GHRS), LB Pharmaceuticals Inc (LBRX), Alto Neuroscience, Inc. (ANRO).